The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route of Administration, Actuation Mechanism, Product Usability, Application Area, Type of Load, Microneedle, Material Used, Intervention and Geography" report has been added to ResearchAndMarkets.com's offering.
The needle-free drug injection system market is expected to reach USD 606 million in the current year and is anticipated to grow at a CAGR of 4% to 2035. Whereas the microneedle devices market is expected to reach USD 2.11 billion in the current year, growing at a CAGR of 6.2% during the forecast period.
Over the years, the incidence rates of chronic diseases, such as diabetes, autoimmune diseases, cardiovascular diseases, and oncological diseases have surged, accounting for major cases of death and disability across the world. In fact, according to the Center for Managing Chronic Disease at the University of Michigan, over 50% of the global population is affected by some form of chronic disease. These conditions pose escalating challenges among patients in terms of cost, mobility and mortality. To address the aforementioned challenges, pharmaceutical companies are adopting various innovative and patient focused strategies.
Currently, oral and parenteral routes are employed for administering prescribed medications to manage such chronic conditions. While oral route of administration is convenient and patient friendly, parenteral administration of drugs is most prevalent approach due to several advantages, including rapid onset of action, precise dosing control and higher bioavailability.
However, it is worth noting that choice of administration route, factors such as properties of drug, condition of patient, desired speed and reliability of therapeutic effects influence the choice of administration route. Despite these advantages offered by the conventional (parenteral) drug delivery approaches, there are various challenges that can hinder medication adherence and ultimately affect the desired therapeutic outcomes. These challenges, particularly with intramuscular and subcutaneous routes include pain during administration, risk of cross contamination, needlestick injuries, and inaccurate dosing.
In response, technological advancement in drug delivery has led to the development of safer alternatives like safety syringes and retractable needle syringes, needle free systems, jet injectors, pen injectors and microneedle patches. These advanced systems enable safer administration of drugs owing to their improved design, functionality and usability in comparison to conventional needles.
This has led towards a discernible shift in patient preferences towards painless drug administration, driving the increasing acceptance and adoption of these systems. Owing to the increasing adoption of needle free drug delivery devices, the market for global needle free drug delivery devices is expected to experience substantial growth during the forecast period.
Key Benefits of Buying this Report
- The report provides valuable insights to market leaders and newcomers related to revenue estimations of the overall market and its sub-segments.
- Stakeholders can utilize the report to enhance their understanding of the competitive landscape, thereby improving their business positioning and developing more effective go-to-market strategies.
- The report provides stakeholders with an overall outlook of the needle free drug delivery devices market, furnishing them with extensive information on significant factors that impact market such as market drivers, barriers, opportunities, and challenges.
Megatrends Analysis
- Technological Innovations
- Applications in Personalized Medicine
- Telemedicine Integration
- Promising Potential in Driving Sustainability
- Robust Regulatory Framework
- Increase in Clinical Trial Activity
Company Profiles
- Antares Pharma (Acquired by Halozyme)
- D'Antonio Consultants International
- HNS International
- INOVIO Pharmaceuticals
- Medical International Technology
- PharmaJet
- Zogenix (acquired by UCB)
- 3M
- Company Overview
- Product Portfolio
- TheraJect
- INJEX Pharma
- Debiotech
- Micropoint Technologies
- Nemaura Pharma
- MIKA MEDICAL
- QS Medical Technology (Quinovare)
- INCYTO
- NanoPass Technologies
Key Topics Covered:
1. Preface
2. Research Methodology
3. Market Dynamics
4. Economic And Other Project Specific Considerations
5. Executive Summary
6. Introduction
7. Market Landscape: Needle-Free Injection Systems
7.1 Chapter Overview
8. Market Landscape: Microneedle Devices
8.1 Chapter Overview
9. Product Competitiveness Analysis: Needle-Free Injection Systems
9.1 Chapter Overview
10. Product Competitiveness Analysis: Microneedle Devices
10.1 Chapter Overview
11. Likely Drug Candidates: Needle-Free Injection Systems
11.1 Chapter Overview
12. Company Profiles: Needle-Free Drug Delivery Device Providers Based In North America
13. Company Profiles: Needle-Free Drug Delivery Device Providers Based In Europe
14. Company Profiles: Needle-Free Drug Delivery Device Providers Based In Asia-Pacific And Rest Of The World
16. Market Impact Analysis
17. Global Needle-Free Injection Systems Market
18. Needle-Free Injection Systems Market, By Product Type
19. Needle-Free Injection Systems Market, By Actuation Mechanism
20. Needle-Free Injection Systems Market, By Product Usability
21. Needle-Free Injection Systems Market, By Type Of Load
22. Needle-Free Injection Systems Market, By Route Of Administration
23. Needle-Free Injection Systems Market, By Application Area
24. Needle-Free Injection Systems Market, By Geography
25. Global Microneedle Devices Market
26. Microneedle Devices Market, By Type Of Microneedle
27. Microneedle Devices Market, By Type Of Material Used
28. Microneedle Devices Market, By Application Area
29. Microneedle Devices Market, By Type Of Intervention
30. Microneedle Devices Market, By Geography
31. Concluding Remarks
32. Executive Insights
33. Appendix I: Tabulated Data
34. Appendix II: List Of Companies And Organizations
For more information about this report visit https://www.researchandmarkets.com/r/krkq3y
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250402332151/en/
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
